• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30
Eden

Eden Unveils the World's First Compounded GLP-1 Rx Gummy

Eden has launched the world's first compounded semaglutide gummy. Designed to deliver the benefits of GLP-1 medications in a convenient, needle-free format, this innovative format reimagines how individuals approach GLP-1 programs in the United States. Eden believes a healthier you means more unforgettable moments. They're tackling America's metabolic health crisis with personalized care and transformative solutions.

Read more →
Thermo Fisher

Thermo Fisher Scientific introduces CTS Detachable Dynabeads CD4 and CD8, advancing cell therapy development and production

Thermo Fisher Scientific Inc., the world leader in serving science, unveiled the Gibco™ CTS™ Detachable Dynabeads™ CD4 and CTS Detachable Dynabeads CD8 (CTS Detachable Dynabeads)*. These latest products expand on Thermo Fisher’s CTS Detachable Dynabeads platform, which represents a new generation of cell therapy isolation and/or activation products that prioritize cell quality while also creating greater workflow control. Ultimately, these products can help customers maximize the potential of their therapies to save more lives.

Read more →
QPS Cell Therapy Unit in Springfield

QPS Launches New Leukopak and Cell Therapy Products Facility

QPS Holdings, LLC announced that their Springfield campus, QPS Missouri, has launched a new Cell Therapy business unit. The unit’s first achievement is the opening of a new Leukopak collection and blood product processing center. This facility is designed to meet the exponentially growing demand for blood products to support cell and gene therapy work.

Read more →